968 Infliximab Use in Patients with Inflammatory Bowel Disease and the Risk of Serious Bacterial Infections
Brian Bressler(University of British Columbia), Sebastian Schneeweiß(Brigham and Women's Hospital), Claire Canning(Brigham and Women's Hospital), Daniel H. Solomon(Brigham and Women's Hospital), Joshua R. Korzenik(Harvard University)
Cited by 4
Related Papers
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Surgery versus Physical Therapy for a Meniscal Tear and Osteoarthritis
|New England Journal of Medicine|2013|653